Skip to main content
Have a personal or library account? Click to login
Biosimilar medical products – licensing, pharmacovigilance and interchangeability Cover

Biosimilar medical products – licensing, pharmacovigilance and interchangeability

PRILOZI
Volume 37 (2016): Issue 1 (June 2016)
By: Aleksandra Grozdanova,  Katerina Ancevska Netkovska,  Zoran Sterjev,  Zorica Naumovska,  Rubin Zarevski,  Aleksandar Dimovski and  Ljubica Suturkova  
Open Access
|Jul 2016
Authors

Authors

Aleksandra Grozdanova

agrozdanova@ff.ukim.edu.mk

Katerina Ancevska Netkovska

Zoran Sterjev

Zorica Naumovska

Rubin Zarevski

Aleksandar Dimovski

Ljubica Suturkova

DOI: https://doi.org/10.1515/prilozi-2016-0006 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 27 - 36
Published on: Jul 15, 2016
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Regulatory,
biosimilars,
biologics,
licensing,
interchangeability,
pharmacovigilance,
EMA
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2016 Aleksandra Grozdanova, Katerina Ancevska Netkovska, Zoran Sterjev, Zorica Naumovska, Rubin Zarevski, Aleksandar Dimovski, Ljubica Suturkova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 37 (2016): Issue 1 (June 2016)
Previous article
Next article